Sinopia Biosciences
Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.Trust70Data Trust: 70/100. Above median. Measured by StartupHub.ai. Median 61.Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
About
Sinopia Biosciences is a biotechnology company focused on developing novel therapeutics. They leverage their proprietary LEADS® (LEarn And DiScover) drug discovery platform, which utilizes metabolomics-driven discovery capabilities. The company has received a research grant from the National Cancer Institute (NCI) to expand the application of its platform to oncology.
Listed competitors
NantHealth provides a suite of healthcare solutions focused on precision medicine and data analytics.
BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.
Enterprise software solutions for biopharmaceutical R&D, accelerating drug discovery and development.
Also in this space
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Oncology
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Shares Biotechnology, Drug Discovery
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Biotech
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Therapeutics
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Drug Discovery
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Biotech
Key facts
- Website
- sinopiabio.com
- Headquarters
- San Diego, California, USA
- Founded
- 2017
- Total funding
- $2M (Grant)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 12 Sept 2025 | Grant | $2M |
Tech stack
Detected on sinopiabio.com, last scanned 31 Oct 2026. Run your own scan
- CMS / Builders
- Squarespace
- Email provider
- Google Workspace
Sinopia Biosciences scores 40. Does yours?
That is its Agent Readiness: how well ChatGPT, Claude and the other agents can read and use a site. Paste your website and you get yours in about a minute.
Frequently asked
Is Sinopia Biosciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Sinopia Biosciences is 70 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Sinopia Biosciences raised?
Sinopia Biosciences has raised a total of $2M in funding. The most recent round on record is Grant.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Sinopia Biosciences
